EGFR and non-small cell lung carcinoma: Moreover, ADAM17 is shown to be required for the proteolysis of Notch1 receptor, which enhances EGFR expression and EGFR-dependent activation of ERK but not AKT in NSCLC cell lines in vitro [187].